Clinical Trials Browser

INDUSTRY × belantamab mafodotin × 90 days × Clear all

NCT04162210 2026-03-31

DREAMM-3

Phase 3 Active not recruiting

325 enrolled 10 charts

Multiple Myeloma

NCT07224672 2026-03-17

ALANIS

Phase 2 Not yet recruiting

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT05714839 2026-01-23

DREAMM-20

Phase 1/2 Recruiting

Multiple Myeloma, Recurrence